Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	The Word Brain 2015 – Free PDF | Print | Web A short guide to fast language learning	Free Abstracts

Parkinson's Disease

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 36 articles: HTML format Text format

Single Articles

November 2012
1. ZIEGLER DA , Wonderlick JS, Ashourian P, Hansen LA, et al
   Substantia Nigra Volume Loss Before Basal Forebrain Degeneration in Early Parkinson Disease.
   Arch Neurol. 2012 Nov 26:1-7. doi: 10.1001/jamaneurol.2013.
   PubMed     Text format     Abstract available
   
   
   
2. SHULMAN LM , Katzel LI, Ivey FM, Sorkin JD, et al
   Randomized Clinical Trial of 3 Types of Physical Exercise for Patients With Parkinson Disease.
   Arch Neurol. 2012 Nov 5:1-8. doi: 10.1001/jamaneurol.2013.
   PubMed     Text format     Abstract available
   
   
   
3. ROSENTHAL LS , Dorsey ER
   The Benefits of Exercise in Parkinson Disease.
   Arch Neurol. 2012 Nov 5:1-2. doi: 10.1001/jamaneurol.2013.
   PubMed     Text format    
   
   
   
4. PERRIN RJ
   Cerebrospinal fluid biomarkers for clinical trials: why markers for differential diagnosis are important.
   Arch Neurol. 2012;69:1407-8.
   PubMed     Text format    
   
   
   October 2012
5. COOPER SE , McIntyre CC, Fernandez HH, Vitek JL, et al
   Association of Deep Brain Stimulation Washout Effects With Parkinson Disease Duration.
   Arch Neurol. 2012 Oct 15:1-5. doi: 10.1001/jamaneurol.2013.
   PubMed     Text format     Abstract available
   
   
   
6. PRODOEHL J , Planetta PJ, Kurani AS, Comella CL, et al
   Differences in Brain Activation Between Tremor- and Nontremor-Dominant Parkinson Disease.
   Arch Neurol. 2012 Oct 8:1-7. doi: 10.1001/archneurol.2013.
   PubMed     Text format     Abstract available
   
   
   
7. DENG H , Liang H, Jankovic J
   F-Box Only Protein 7 Gene in Parkinsonian-Pyramidal Disease.
   Arch Neurol. 2012 Oct 1:1-5. doi: 10.1001/archneurol.2013.
   PubMed     Text format     Abstract available
   
   
   
8. GAO X , Simon KC, Schwarzschild MA, Ascherio A, et al
   Age, statin use, and the risk for incident Parkinson disease-reply.
   Arch Neurol. 2012;69:1381.
   PubMed     Text format    
   
   
   
9. ANDRADE C
   Age, statin use, and the risk for incident Parkinson disease.
   Arch Neurol. 2012;69:1381.
   PubMed     Text format    
   
   
   September 2012
10. KOTAGAL V , Bohnen NI, Muller ML, Koeppe RA, et al
    Cerebral Amyloid Deposition and Serotoninergic Innervation in Parkinson Disease.
    Arch Neurol. 2012 Sep 10:1-4. doi: 10.1001/archneurol.2012.
    PubMed     Text format     Abstract available
    
    
    
11. ROCCA WA
    Families With Parkinson Disease and Cancer.
    Arch Neurol. 2012 Sep 3:1-2. doi: 10.1001/archneurol.2012.2664.
    PubMed     Text format    
    
    
    
12. KAREUS SA , Figueroa KP, Cannon-Albright LA, Pulst SM, et al
    Shared Predispositions of Parkinsonism and Cancer: A Population-Based Pedigree-Linked Study.
    Arch Neurol. 2012 Sep 3:1-6. doi: 10.1001/archneurol.2012.2261.
    PubMed     Text format     Abstract available
    
    
    August 2012
13. HALL S , Ohrfelt A, Constantinescu R, Andreasson U, et al
    Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders.
    Arch Neurol. 2012 Aug 27:1-8. doi: 10.1001/archneurol.2012.1654.
    PubMed     Text format     Abstract available
    
    
    July 2012
14. WANG HC , Hsu JL, Leemans A
    Diffusion Tensor Imaging of Vascular Parkinsonism: Structural Changes in Cerebral White Matter and the Association With Clinical Severity.
    Arch Neurol. 2012 Jul 23:1-9. doi: 10.1001/archneurol.2012.
    PubMed     Text format     Abstract available
    
    
    
15. KOTZBAUER PT , Cairns NJ, Campbell MC, Willis AW, et al
    Pathologic Accumulation of alpha-Synuclein and Abeta in Parkinson Disease Patients With Dementia.
    Arch Neurol. 2012 Jul 23:1-6. doi: 10.1001/archneurol.2012.1608.
    PubMed     Text format     Abstract available
    
    
    
16. KUMAR KR , Weissbach A, Heldmann M, Kasten M, et al
    Frequency of the D620N Mutation in VPS35 in Parkinson Disease.
    Arch Neurol. 2012 Jul 16:1-5. doi: 10.1001/archneurol.2011.3367.
    PubMed     Text format     Abstract available
    
    
    April 2012
17. GITCHEL GT , Wetzel PA, Baron MS
    Pervasive Ocular Tremor in Patients With Parkinson Disease.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    March 2012
18. GARRAUX G , Caberg JH, Vanbellinghen JF, Jamar M, et al
    Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.
    Arch Neurol. 2012;69:398-400.
    PubMed     Text format     Abstract available
    
    
    
19. GAO X , Simon KC, Schwarzschild MA, Ascherio A, et al
    Prospective study of statin use and risk of Parkinson disease.
    Arch Neurol. 2012;69:380-4.
    PubMed     Text format     Abstract available
    
    
    
20. CRISWELL SR , Perlmutter JS, Crippin JS, Videen TO, et al
    Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.
    Arch Neurol. 2012;69:394-7.
    PubMed     Text format     Abstract available
    
    
    
21. REEVE AK , Park TK, Jaros E, Campbell GR, et al
    Relationship between mitochondria and alpha-synuclein: a study of single substantia nigra neurons.
    Arch Neurol. 2012;69:385-93.
    PubMed     Text format     Abstract available
    
    
    February 2012
22. ROOHI FF
    Hyperthermia and jaw opening in drug-induced movement disorders.
    Arch Neurol. 2012;69:279.
    PubMed     Text format    
    
    
    January 2012
23. WILLIS AW , Schootman M, Kung N, Evanoff BA, et al
    Predictors of Survival in Patients With Parkinson Disease.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    
24. GAN-OR Z , Bar-Shira A, Dahary D, Mirelman A, et al
    Association of Sequence Alterations in the Putative Promoter of RAB7L1 With a Reduced Parkinson Disease Risk.
    Arch Neurol. 2012;69:105-10.
    PubMed     Text format     Abstract available
    
    
    December 2011
25. DELUCA GC , Li G, Ramagopalan S
    Parkinson disease and vitamin d: an interplay between genes and the environment?
    Arch Neurol. 2011;68:1615-6.
    PubMed     Text format    
    
    
    
26. WEINTRAUB D , Doshi J, Koka D, Davatzikos C, et al
    Neurodegeneration across stages of cognitive decline in Parkinson disease.
    Arch Neurol. 2011;68:1562-8.
    PubMed     Text format     Abstract available
    
    
    August 2011
27. CASTRIOTO A , Lozano AM, Poon YY, Lang AE, et al
    Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation.
    Arch Neurol. 2011.
    PubMed     Text format     Abstract available
    
    
    
28. KIPFER S , Stephan MA, Schupbach WM, Ballinari P, et al
    Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia.
    Arch Neurol. 2011;68:1037-9.
    PubMed     Text format     Abstract available
    
    
    
29. SAVICA R , Matsumoto JY, Josephs KA, Ahlskog JE, et al
    Deep brain stimulation in benign tremulous parkinsonism.
    Arch Neurol. 2011;68:1033-6.
    PubMed     Text format     Abstract available
    
    
    
30. KATZ M , Kilbane C, Rosengard J, Alterman RL, et al
    Referring patients for deep brain stimulation: an improving practice.
    Arch Neurol. 2011;68:1027-32.
    PubMed     Text format     Abstract available
    
    
    July 2011
31. BERG D , Seppi K, Behnke S, Liepelt I, et al
    Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.
    Arch Neurol. 2011;68:932-7.
    PubMed     Text format     Abstract available
    
    
    
32. GODAU J , Knauel K, Weber K, Brockmann K, et al
    Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease.
    Arch Neurol. 2011;68:925-31.
    PubMed     Text format     Abstract available
    
    
    
33. WEINTRAUB D , Chen P, Ignacio RV, Mamikonyan E, et al
    Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.
    Arch Neurol. 2011;68:899-904.
    PubMed     Text format     Abstract available
    
    
    June 2011
34. KLEIN C , Krainc D, Schlossmacher MG, Lang AE, et al
    Translational research in neurology and neuroscience 2011: movement disorders.
    Arch Neurol. 2011;68:709-16.
    PubMed     Text format     Abstract available
    
    
    May 2011
35. ROBOTTOM BJ , Weiner WJ, Factor SA
    Movement disorders emergencies. Part 1: Hypokinetic disorders.
    Arch Neurol. 2011;68:567-72.
    PubMed     Text format     Abstract available
    
    
    February 2011
36. MORENO-LOPEZ C , Santamaria J, Salamero M, Del Sorbo F, et al
    Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).
    Arch Neurol. 2011;68:223-30.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: